Stock Information
United Therapeutics Corp (UTHR)
Ticker Symbol: UTHR
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $24,318.80 mil
Piotroski score: 5
PE Ratio: 18.934
EPS (TTM): 27.9001
Revenue (TTM): $67.29 M
Dividend Yield: N/A%
ROE: 19.3%
Latest News
-
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Thu, Apr 16, 2026 1:00 PM
-
Surrozen (SRZN) Surges 5.9%: Is This an Indication of Further Gains?
Tue, Apr 14, 2026 1:28 PM
-
Truist Securities Touts MannKind Corporation (MNKD) Prospects on Tyvaso Franchise Development
Tue, Apr 14, 2026 9:50 AM
-
United Therapeutics RMAT Win Puts Organ Manufacturing Platform In Focus
Mon, Apr 13, 2026 1:07 PM
-
United Therapeutics price target raised to $519 from $471 at Morgan Stanley
Sat, Apr 11, 2026 12:57 PM
-
Nike downgraded, IBM initiated: Wall Street's top analyst calls
Fri, Apr 10, 2026 1:37 PM
-
Morgan Stanley Maintains Equal-Weight on United Therapeutics, Raises Price Target to $519
Fri, Apr 10, 2026 12:10 PM
-
Here Are Friday’s Top Wall Street Analyst Research Calls: Autodesk, Delek US Holdings, Insmed, Nike, Nutanix, ServiceNow, Shake Shack, Southern Copper, Veeva Systems, and More
Fri, Apr 10, 2026 11:51 AM
Key Financials
Financial data not available
